• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

竞争事件分析,如死因特异性死亡率——警惕 Kaplan-Meier 法。

The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method.

机构信息

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Nephrol Dial Transplant. 2011 Jan;26(1):56-61. doi: 10.1093/ndt/gfq661. Epub 2010 Nov 8.

DOI:10.1093/ndt/gfq661
PMID:21059831
Abstract

Kaplan-Meier analysis is a popular method used for analysing time-to-event data. In case of competing event analyses such as that of cardiovascular and non-cardiovascular mortality, however, the Kaplan-Meier method profoundly overestimates the cumulative mortality probabilities for each of the separate causes of death. This article provides an introduction to the problem of competing events in Kaplan-Meier analysis. It explains cumulative incidence competing risk analysis and demonstrates on a cohort of elderly dialysis patients that, in contrast to the Kaplan-Meier method, application of this method yields unbiased estimates of the cumulative probabilities for cause-specific mortality.

摘要

Kaplan-Meier 分析是一种常用于分析时间事件数据的流行方法。然而,在竞争事件分析中,例如心血管和非心血管死亡率的分析,Kaplan-Meier 方法会严重高估每个单独死亡原因的累积死亡率概率。本文介绍了 Kaplan-Meier 分析中竞争事件的问题。它解释了累积发生率竞争风险分析,并在老年透析患者队列上进行了演示,与 Kaplan-Meier 方法相比,应用该方法可以对特定原因死亡率的累积概率进行无偏估计。

相似文献

1
The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method.竞争事件分析,如死因特异性死亡率——警惕 Kaplan-Meier 法。
Nephrol Dial Transplant. 2011 Jan;26(1):56-61. doi: 10.1093/ndt/gfq661. Epub 2010 Nov 8.
2
Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method.采用Kaplan-Meier法对前列腺癌死亡率及其他原因死亡率的高估。
Can J Urol. 2013 Jun;20(3):6756-60.
3
Peritonitis-free survival in peritoneal dialysis: an update taking competing risks into account.腹膜透析患者的腹膜炎无进展生存率:考虑竞争风险的更新。
Nephrol Dial Transplant. 2010 Jul;25(7):2315-22. doi: 10.1093/ndt/gfq003. Epub 2010 Jan 25.
4
[Is Kaplan-Meier statistics the most appropriate tool for survivorship measurement of outcomes in orthopaedics?].[Kaplan-Meier统计法是骨科结果生存测量的最合适工具吗?]
Acta Chir Orthop Traumatol Cech. 2010 Apr;77(2):118-23.
5
Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.骨肉瘤患者的竞争风险分析:四种不同方法的比较。
Stat Med. 2001 Mar 15;20(5):661-84. doi: 10.1002/sim.711.
6
Competing events influence estimated survival probability: when is Kaplan-Meier analysis appropriate?竞争事件会影响估计的生存概率:Kaplan-Meier分析何时适用?
Clin Orthop Relat Res. 2007 Sep;462:229-33. doi: 10.1097/BLO.0b013e3180986753.
7
Analysing clinical studies: principles, practice and pitfalls of Kaplan-Meier plots.分析临床研究:Kaplan-Meier曲线的原理、实践与陷阱
ANZ J Surg. 2008 Mar;78(3):204-10. doi: 10.1111/j.1445-2197.2007.04405.x.
8
Time-related analysis of nonfatal heart valve complications: cumulative incidence (actual) versus Kaplan-Meier (actuarial).非致命性心脏瓣膜并发症的时间相关分析:累积发病率(实际)与Kaplan-Meier法(精算)。
Circulation. 1997 Nov 4;96(9 Suppl):II-70-4; discussion II-74-5.
9
Another view on the analysis of cardiovascular morbidity/mortality trials.
Pharm Stat. 2011 May-Jun;10(3):196-202. doi: 10.1002/pst.434. Epub 2010 Apr 22.
10
Introduction to the Analysis of Survival Data in the Presence of Competing Risks.存在竞争风险时生存数据的分析导论
Circulation. 2016 Feb 9;133(6):601-9. doi: 10.1161/CIRCULATIONAHA.115.017719.

引用本文的文献

1
Competing Risks Analysis of the Finnish Diabetes Prevention Study.芬兰糖尿病预防研究的竞争风险分析
CPT Pharmacometrics Syst Pharmacol. 2025 Sep;14(9):1459-1469. doi: 10.1002/psp4.70065. Epub 2025 Jun 30.
2
"Long-term effects of center volume on transplant outcomes in adult kidney transplant recipients"."中心体积对成人肾移植受者移植结局的长期影响"。
PLoS One. 2024 Jun 6;19(6):e0301425. doi: 10.1371/journal.pone.0301425. eCollection 2024.
3
The "Can Do, Do Do" Framework Applied to Assess the Association between Physical Capacity, Physical Activity and Prospective Falls, Subsequent Fractures, and Mortality in Patients Visiting the Fracture Liaison Service.
应用“能做,就做”框架评估骨折联络服务门诊患者的身体能力、身体活动与预期跌倒、随后骨折及死亡率之间的关联。
J Pers Med. 2024 Mar 23;14(4):337. doi: 10.3390/jpm14040337.
4
Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death.葡萄膜黑色素瘤的综合死因:1530 例连续诊断患者的死亡率,直至死亡。
JNCI Cancer Spectr. 2023 Oct 31;7(6). doi: 10.1093/jncics/pkad097.
5
Construction and validation of a prognostic nomogram for predicting cancer-specific survival in patients with intermediate and advanced colon cancer after receiving surgery and chemotherapy.用于预测中晚期结肠癌患者接受手术和化疗后癌症特异性生存的预后列线图的构建与验证
J Cancer Res Clin Oncol. 2023 Nov;149(14):12821-12834. doi: 10.1007/s00432-023-05154-7. Epub 2023 Jul 17.
6
Competing risk models to evaluate the factors for time to loss to follow-up among tuberculosis patients at Ambo General Hospital.用于评估安博综合医院结核病患者失访时间相关因素的竞争风险模型。
Arch Public Health. 2023 Jun 25;81(1):117. doi: 10.1186/s13690-023-01130-2.
7
Prediction of thrombosis in polycythemia vera: Development and validation of a multiple factor-based prognostic score system.真性红细胞增多症中血栓形成的预测:基于多因素的预后评分系统的开发与验证
Res Pract Thromb Haemost. 2023 Mar 28;7(3):100132. doi: 10.1016/j.rpth.2023.100132. eCollection 2023 Mar.
8
Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study.建立和验证用于预测三阴性乳腺癌肿瘤特异性死亡风险的列线图:基于监测、流行病学和最终结果(SEER)队列研究的竞争风险模型
Gland Surg. 2022 Dec;11(12):1961-1975. doi: 10.21037/gs-22-650.
9
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma.肾细胞癌中肿瘤血栓的患病率、治疗及预后
JACC CardioOncol. 2022 Nov 15;4(4):522-531. doi: 10.1016/j.jaccao.2022.07.011. eCollection 2022 Nov.
10
Long-term relative survival in uveal melanoma: a systematic review and meta-analysis.葡萄膜黑色素瘤的长期相对生存率:一项系统评价和荟萃分析。
Commun Med (Lond). 2022 Mar 1;2:18. doi: 10.1038/s43856-022-00082-y. eCollection 2022.